Other Income & Expense

Unrealized Gain (Loss) on Equity Securities

Vertex Pharmaceuticals Unrealized Gain (Loss) on Equity Securities remained flat by 0.0% to -$2.83M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 18.9%, from -$2.38M to -$2.83M. Over 2 years (FY 2023 to FY 2025), Unrealized Gain (Loss) on Equity Securities shows a downward trend with a 22.7% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementIncome Statement
SectionOther Income & Expense
CategoryOther
SignalHigher is better
VolatilityVolatile
First reportedQ1 2016
Last reportedQ4 2025

How to read this metric

High volatility indicates significant exposure to market fluctuations in the company's investment portfolio, which can distort net income.

Detailed definition

Changes in the fair value of equity investments held by the company that are recognized in the income statement. These g...

Peer comparison

Common for companies with large corporate venture capital or strategic investment portfolios.

Metric ID: is_wmt_unrealized_gain_loss_equity_securities

Historical Data

3 years
 FY'23FY'24FY'25
Value-$7.50M-$9.50M-$11.30M
YoY Change—-26.7%-18.9%
Range-$11.30M – -$7.50M
CAGR+22.7%
Avg YoY Growth-22.8%
Median YoY Growth-22.8%
Current Streak2+ years decline

Frequently Asked Questions

What is Vertex Pharmaceuticals's unrealized gain (loss) on equity securities?
Vertex Pharmaceuticals (VRTX) reported unrealized gain (loss) on equity securities of -$2.83M in Q4 2025.
How has Vertex Pharmaceuticals's unrealized gain (loss) on equity securities changed year-over-year?
Vertex Pharmaceuticals's unrealized gain (loss) on equity securities decreased by 18.9% year-over-year, from -$2.38M to -$2.83M.
What is the long-term trend for Vertex Pharmaceuticals's unrealized gain (loss) on equity securities?
Over 2 years (2023 to 2025), Vertex Pharmaceuticals's unrealized gain (loss) on equity securities has grown at a 22.7% compound annual growth rate (CAGR), from -$7.50M to -$11.30M.
What does unrealized gain (loss) on equity securities mean?
Paper gains or losses on stock investments held by the company.